Summary
1. Antisense oligodeoxynucleotides (ODNs) internally labeled with biotin or digoxigenin were injected into the lateral ventricle of rats and the distribution of the labeled ODNs was examined at several timepoints following the intracerebroventricular (icv) injections. The stability of these injected antisense ODNs, which had no backbone modifications, was also studied by performing recovery experiments.
2. The most intense labeling was observed near the injection site, in periventricular areas, and in perivascular regions. Many of the labeled cells appeared to be neurons, and both the cytoplasm and the nuclei were stained. The labeled cells were detected 15 min after icv injection, demonstrating that the antisense ODNs were taken up rapidly by cells in the parenchyma. The digoxigeninated antisense ODNs were presented in both the cytoplasmic and the nuclear fractions of rat brain extracts, however, the levels appeared to be much lower in the nuclear fractions.
3. Antisense ODNs injected into the lateral ventricle seemed to follow the bulk flow of cerebrospinal fluid (CSF), i.e., from the injection site in the lateral ventricle, through the ventricular system, to the subarachnoid spaces and the perivascular spaces. From the ventricular and perivascular spaces, the antisense ODNs diffused into the extracellular space and were taken up by cells. The full-length digoxigeninated antisense ODNs were detectable within cells after only 15 min, indicating their rapid uptake. In addition, the antisense ODNs appeared to be relatively stable in the brain since the full-length digoxigeninated ODNs were still detectable after 4 hr.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Caceres, A., and Kosik, K. S. (1990). Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons.Nature 343461–463.
Crooke, S. T. (1992). Therapeutic applications of oligonucleotides.Annu. Rev. Pharmacol. Toxicol. 32329–376.
Faustmann, P. M., Teutrine, S., Krause, D., and Dermietzel, R. (1991). Subarachnoid macrophages share a common epitope with resident non-cerebral macrophages and show receptor-mediated endocytosis of albumin-gold and IgG-gold complexes.J. Neuroimmunol. 3579–88.
Ghosh, M. K., and Cohen, J. S. (1992). Oligodeoxynucleotides as antisense inhibitors of gene expression.Prog. Nucleic Acid Res. Mol. Biol. 4279–126.
Helene, C., and Toulme, J.-J. (1990). Specific regulation of gene regulation by antisense, sense and antigene nucleic acids.Biochim. Biophys. Acta 104999–125.
Ichimura, T., Fraser, P. A., and Cserr, H. F. (1991). Distribution of extracellular tracers in perivascular spaces of the rat brain.Brain Res. 545103–113.
Kida, S., Steart, P., Zhang, E.-T., and Weller, R. O. (1993). Perivascular cells act as scavengers in the cerebral perivascular spaces and remain distinct from pericytes, microglia and macrophages.Acta Neuropathol. 85646–652.
Leonetti, J. P., Mechti, N., Degols, G., Gagnor, C., and Lebleu, B. (1991). Intracellular distribution of microinjected antisense oligonucleotides.Proc. Natl. Acad. Sci. USA 882702–2706.
Loke, S. L., Stein, C. A., Zhang, X. H., Mori, K., Nakanishi, M., Subasinghe, C., Cohen, J. S., and Neckers, L. M. (1989). Characterization of oligonucleotide transport into living cells.Proc. Natl. Acad. Sci. USA 863474–3478.
McCarthy, M. M., Schlenker, E. H., and Pfaff, D. W. (1993). Enduring consequences of neonatal treatment with antisense oligodeoxynucleotides to estrogen receptor messenger ribonucleic acid on sexual differentiation of rat brain.Endocrinology 133433–439.
Melton, D. A. (1985). injected anti-sense RNAs specifically block messenger RNA translationin vivo.Proc. Natl. Acad. Sci. USA 82144–148.
Paxinos, G., and Watson, C. (1986).The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989).Molecular Cloning, a Laboratory Manual, 2nd ed., Cold Springer Harbor Laboratory Press; Cold Springer Harbor, NY.
Sommer, W., Bjelke, B., Ganten, D., and Fuxe, K. (1993). Antisense oligonucleotide to c-fos induces ipsilateral rotational behaviour tod-amphetamine.Neuroreport 5277–280.
Wahlestedt, C. (1994). Antisense oligonucleotide strategies in neuropharmacology.Trends Pharmacol. Sci. 1542–46.
Wahlestedt, C., Golanov, E., Yamamoto, S., Yee, F., Ericson, H., Yoo, H., Inturrisi, C. E., and Reis, D. J. (1993a). Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.Nature 363260–263.
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., and Heilig, M. (1993b). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.Science 259528–531.
Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J. R., and Neckers, L. M. (1993). Stability, clearance, and disposition of intraventricularly administered oligodeoxynucleotides: Implications for therapeutic application within the central nervous system.Proc. Natl. Acad. Sci. USA 904665–4669.
Woolf, T. M., Melton, D. A., and Jennings, C. G. B. (1992). Specificity of antisense oligonucleotidesin vivo.Proc. Natl. Acad. Sci. USA 897305–7309.
Yakubov, L. A., Deeva, E. A., Zarytova, V. F., Ivanova, E. M., Ryte, A. S., Yurchenko, L. V., and Vlassov, V. V. (1989). Mechanism of oligonucleotide uptake by cells: Involvement of specific receptors?Proc. Natl. Acad. Sci. USA 866454–6458.
Zhang, E.-T., Richards, H. K., Kida, S., and Weller, R. O. (1992). Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain.Acta Neuropathol. 83233–239.
Zhang, M., and Creese, I. (1993). Antisense oligonucleotides reduces brain dopamine D2 receptors: Behavioral correlates.Neurosci. Lett. 161223–226.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yee, F., Ericson, H., Reis, D.J. et al. Cellular uptake of intracerebroventricularly administered biotin- or digoxigenin-Labeled antisense oligodeoxynucleotides in the rat. Cell Mol Neurobiol 14, 475–486 (1994). https://doi.org/10.1007/BF02088832
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02088832